TNF inhibitors help treat autoimmune diseases but can reactivate latent tuberculosis. Screening with TST or IGRA, proper LTBI treatment, and ongoing monitoring are essential to prevent serious, sometimes fatal, TB cases. Risk varies by drug class - etanercept is safer than infliximab or adalimumab.
Learn more...